Compare Amphastar Pharmaceuticals Inc (AMPH) vs Pinterest Inc (PINS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Pinterest Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $18.72 (market cap $826.08M), while Pinterest Inc trades at $22.72 (market cap $12.61B). The key difference: Pinterest Inc is far larger — about 15.3× Amphastar Pharmaceuticals Inc's market cap, and Pinterest Inc is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | PINS | |
|---|---|---|
Market Cap | $826.08M | $12.61B |
Sector | Health | Media |
52-Week High | $30.81 | $39.17 |
52-Week Low | $16.87 | $15.42 |
Enterprise Value | $1.22B | $12.52B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
Pinterest (PINS) trades at $22.53, down 0.71% on the day, with a bullish technical outlook supported by moving averages. The company reported revenue growth to $4.22B in 2025, with net income of $416.86M and a net margin of 9.87%. Recent news highlights AI-driven shopping initiatives and strong user growth, while analyst sentiment remains positive with a consensus price target of $27.72.
The stock presents a growth opportunity with improving profitability and strategic AI investments, but faces risks from competitive pressure and valuation concerns. Wall Street's bullish consensus suggests upside potential, though investors should monitor execution on monetization and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →
